SCM
BLUE

Sterling Capital Management’s bluebird bio BLUE Stock Holding History

Sterling Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-175
Closed -$854 – 3281
2025
Q1 		$854 Sell
175
-150
-46% -$902 ﹤0.01% 2863
2024
Q4 		$2.71K Buy
325
+295
+983% +$2.58K ﹤0.01% 2692
2024
Q3 		$316 Buy
+30
New +$499 ﹤0.01% 3017
2017
Q4 		– Sell
-197
Closed -$351K – 891
2017
Q3 		$351K Buy
+197
New +$275K ﹤0.01% 810
2017
Q2 		– Sell
-191
Closed -$225K – 940
2017
Q1 		$225K Buy
+191
New +$195K ﹤0.01% 896

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sterling Capital Management's BLUE Position: Q2 2025 in Review

Sterling Capital Management sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 175 shares — an estimated $854 sold.

Sterling Capital Management first reported a position in BLUE in Q1 2017 and held it in 5 quarters. The position peaked at $351K in Q3 2017. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Sterling Capital Management reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Sterling Capital Management sold 175 bluebird bio shares in Q2 2025, an estimated $854.
  • Sterling Capital Management first reported a position in bluebird bio in Q1 2017 and held it in 5 quarters.
  • Sterling Capital Management's bluebird bio position peaked at $351K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Sterling Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.